Long-Term Outcomes of Anti-T-Lymphocyte Globulin Added to Graft-Versus-Host Disease Prophylaxis
GVHD prophylaxis including anti-T-lymphocyte globulin was associated with improved survival and quality of life.
All articles by Megan Garlapow, PhD
Azacitidine Maintenance May Improve Disease-Free Survival in Newly Diagnosed Acute Myeloid Leukemia
Over half of patients receiving azacitidine maintenance achieved protocol completion, supporting the feasibility of this therapeutic approach.
Durable Post-Transplant Remission in Multiple Myeloma Regardless of Conditioning Regimen
Each of 3 reduced intensity conditioning regimens yielded similar clinical outcomes in patients with multiple myeloma undergoing allogeneic stem cell transplant.
Increased Sirolimus Serum Concentration Associated With Decreased Cytomegalovirus DNAemia
Sirolimus treatment of patients undergoing allogeneic hematopoietic stem cell transplantation may prevent cytomegalovirus infection.
Use of Rotational Thromboelastometry With Ristocetin to Identify Clinically Relevant von Willebrand Disease
Using rotational thromboelastometry may allow assessment of bleeding risks in patients with clinically relevant von Willebrand disease.
Immunobiological Features of B Cell Acute Lymphoblastic Leukemia in Adults
Researchers found some immunobiological profiles specific to patients with acute lymphoblastic leukemia.
Researchers Review Coagulation Risk Factors in Neonates and Children
The interactions between von Willebrand factors and its cleaving protease ADAMTS-13 recently emerged as risk factors for pediatric thromboembolism.
Self-Reported Bleeding Symptoms May Not Be Associated With Greater Fibrinolytic Activity
Propensity for bleeding was previously thought to relate to greater fibrinolytic activity, but this may not be the case.
Statin Therapy May Reduce Thrombin Generation Potential in Patients With Thromboembolism
Statins may provide a therapeutic alternative to anticoagulant prophylaxis for venous thromboembolism.
Using Diluent Buffer May Lead to Overestimation of Low Factor VIII Levels
Accurate measurement of low factor VIII levels is necessary for proper monitoring of factor VIII replacement therapy.
Next post in Bleeding Disorders
